Use of Radiomics Combined With Machine Learning Method in the Recurrence Patterns After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Preliminary Study

Shuangshuang Li, Kongcheng Wang, Zhen Hou, Ju Yang, Wei Ren, Shanbao Gao, Fanyan Meng, Puyuan Wu, Baorui Liu, Juan Liu, Jing Yan, Shuangshuang Li, Kongcheng Wang, Zhen Hou, Ju Yang, Wei Ren, Shanbao Gao, Fanyan Meng, Puyuan Wu, Baorui Liu, Juan Liu, Jing Yan

Abstract

Objective: To analyze the recurrence patterns and reasons in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT) and to investigate the feasibility of radiomics for analysis of radioresistance. Methods: We analyzed 306 NPC patients treated with IMRT from Jul-2009 to Aug-2016, 20 of whom developed with recurrence. For the NPCs with recurrence, CT, MR, or PET/CT images of recurrent disease were registered with the primary planning CT for dosimetry analysis. The recurrences were defined as in-field, marginal or out-of-field, according to dose-volume histogram (DVH) of the recurrence volume. To explore the predictive power of radiomics for NPCs with in-field recurrences (NPC-IFR), 16 NPCs with non-progression disease (NPC-NPD) were used for comparison. For these NPC-IFRs and NPC-NPDs, 1117 radiomic features were quantified from the tumor region using pre-treatment spectral attenuated inversion-recovery T2-weighted (SPAIR T2W) magnetic resonance imaging (MRI). Intraclass correlation coefficients (ICC) and Pearson correlation coefficient (PCC) was calculated to identify influential feature subset. Kruskal-Wallis test and receiver operating characteristic (ROC) analysis were employed to assess the capability of each feature on NPC-IFR prediction. Principal component analysis (PCA) was performed for feature reduction. Artificial neural network (ANN), k-nearest neighbor (KNN), and support vector machine (SVM) models were trained and validated by using stratified 10-fold cross validation. Results: The median follow up was 26.5 (range 8-65) months. 9/20 (45%) occurred in the primary tumor, 8/20 (40%) occurred in regional lymph nodes, and 3/20 (15%) patients developed a primary and regional failure. Dosimetric and target volume analysis of the recurrence indicated that there were 18 in-field, and 1 marginal as well as 1 out-of-field recurrence. With pre-therapeutic SPAIR T2W MRI images available, 11 NPC-IFRs (11 of 18 NPC-IFRs who had available pre-therapeutic MRI) and 16 NPC-NPDs were subsequently employed for radiomic analysis. Results showed that NPC-IFRs vs. NPC-NPDs could be differentiated by 8 features (AUCs: 0.727-0.835). The classification models showed potential in prediction of NPC-IFR with higher accuracies (ANN: 0.812, KNN: 0.775, SVM: 0.732). Conclusion: In-field and high-dose region relapse were the main recurrence patterns which may be due to the radioresistance. After integration in the clinical workflow, radiomic analysis can be served as imaging biomarkers to facilitate early salvage for NPC patients who are at risk of in-field recurrence.

Keywords: intensity-modulated radiotherapy; nasopharyngeal carcinoma; prediction; radiomic analysis; recurrence pattern.

Figures

Figure 1
Figure 1
Patterns of failure for patients with recurrence, with the accumulated dose and site of recurrence. (A) In field. (B) Out of field. (C) Marginal.
Figure 2
Figure 2
Flowchart of using radiomic analysis in recurrent pattern.
Figure 3
Figure 3
(A) Workflow of radiomic analysis for discrimination between NPC-IFR (NPC with in-field recurrence) and NPC-NPD (NPC with non-progression disease). I, Image segmentation was performed on SPAIR T2W MR images. II, Features were extracted from the tumor contours on the MR images using shape, first order, texture, LoG and wavelet-based method. III, Principal component analysis (PCA) was performed on significant features for dimension reduction. IV, For the analysis, principal components derived from significant features were combined with supervised machine learning method for prediction of NPC-IFR vs. NPC-NPD. (B) Examples of feature maps computed from two-dimensional tumor region by using GLCM method (e.g., Energy, Entropy, Correlation, InverseDifferenceMoment [IDM]).
Figure 4
Figure 4
Box plots of amplitude features, successfully differentiating NPC-IFR from NPC-NPD. (A) glcm_CT (P = 0.046); (B) WHLL_gldm_DE (P = 0.023); (C) WHLH_F_RMS (P = 0.023); (D) WHLL_glcm_CP (P = 0.032); (E) WHLL_ngtdm_Complexity (P = 0.041); (F) WHLH_glcm_IMC (P = 0.041); (G) WHLL_gldm_SDLGLE (P = 0.048); (H) WLLH_ngtdm_Strength (P = 0.048).
Figure 5
Figure 5
Pearson correlation coefficient of the eight significant features.
Figure 6
Figure 6
(A) Receiver operating characteristics (ROC) curves on the basis of the significant features. (B) Three-dimensional scatter plot of the NPC-IFR and NPC-NPD by using three principal components derived from the above eight significant features.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2018) 68:394–424. 10.3322/caac.21492
    1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. . Cancer statistics in China, 2015. CA Cancer J Clin. (2016) 66:115–32. 10.3322/caac.21338
    1. Lee N, Puri DR, Blanco AI, Chao K. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck. (2007) 29:387–400. 10.1002/hed.20332
    1. Wang L, Guo Y, Xu J, Chen Z, Jiang X, Zhang L, et al. . Clinical analysis of recurrence patterns in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Ann Otol Rhinol Laryngol. (2017) 126:789–97. 10.1177/0003489417734229
    1. Li J-X, Huang S-M, Jiang X-H, Ouyang B, Han F, Liu S, et al. . Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Radiat Oncol. (2014) 9:87. 10.1186/1748-717X-9-87
    1. Kong F, Ying H, Du C, Huang S, Zhou J, Chen J, et al. . Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiat Oncol. (2014) 9:60. 10.1186/1748-717X-9-60
    1. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, et al. . Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer. Radiat Oncol. (2017) 12:87. 10.1186/s13014-017-0829-5
    1. Oksuz DC, Prestwich RJ, Carey B, Wilson S, Senocak MS, Choudhury A, et al. . Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol. (2011) 6:54. 10.1186/1748-717X-6-54
    1. Fave X, Mackin D, Lee J, Yang J, Zhang L. Computational resources for radiomics. Transl Cancer Res. (2016) 5:340–8. 10.21037/tcr.2016.06.17
    1. Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, et al. . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. (2014) 5:4006. 10.1038/ncomms5006
    1. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. . Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (2012) 48:441. 10.1016/j.ejca.2011.11.036
    1. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology (2016) 278:563. 10.1148/radiol.2015151169
    1. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. . Radiomics: the process and the challenges. Magn Reson Imaging (2012) 30:1234–48. 10.1016/j.mri.2012.06.010
    1. Jethanandani A, Lin TA, Volpe S, Elhalawani H, Mohamed AS, Yang P, et al. . Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review. Front Oncol. (2018) 8:131. 10.3389/fonc.2018.00131
    1. Del Grande F, Santini F, Herzka DA, Aro MR, Dean CW, Gold GE, et al. Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system. Radiographics (2014) 34:217–33. 10.1148/rg.341135130
    1. Tien RD, Hesselink J, Chu P, Szumowski J. Improved detection and delineation of head and neck lesions with fat suppression spin-echo MR imaging. Am J Neuroradiol. (1991) 12:19–24.
    1. Tang C, Wu F, Wang R, Lu H, Li G, Liu M, et al. . Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial. Am J Cancer Res. (2016) 6:2064.
    1. Tang L-Q, Chen D-P, Guo L, Mo H-Y, Huang Y, Guo S-S, et al. . Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. (2018) 19:461–73. 10.1016/S1470-2045(18)30104-9
    1. Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, et al. . Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Jpn J Clin Oncol. (2010) 40:425–31. 10.1093/jjco/hyp183
    1. Cao K-J, Zhang A-L, Ma W-J, Huang P-Y, Luo D-H, Xia W-X. Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage III-IVa nasopharyngeal carcinoma: a randomized controlled study. Chinese J Oncol. (2011) 33:50–2. 10.3760/cma.j.issn.0253-3766.2011.01.011
    1. Collewet G, Strzelecki M, Mariette F. Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging (2004) 22:81–91. 10.1016/j.mri.2003.09.001
    1. van Griethuysen JJ, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. (2017) 77:e104–7. 10.1158/0008-5472.CAN-17-0339
    1. Hong B, Lui VWY, Hashiguchi M, Hui EP, Chan ATC. Targeting tumor hypoxia in nasopharyngeal carcinoma. Head Neck (2013) 35:133–45. 10.1002/hed.21877
    1. Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology (2013) 266:326–36. 10.1148/radiol.12112428
    1. Zhang B, He X, Ouyang F, Gu D, Dong Y, Zhang L, et al. . Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett. (2017) 403:21. 10.1016/j.canlet.2017.06.004
    1. Cook GJR, Siddique M, Taylor BP, Yip C, Chicklore S, Goh V. Radiomics in PET: principles and applications. Clin Transt Imaging (2014) 2:269–76. 10.1007/s40336-014-0064-0

Source: PubMed

3
Suscribir